# Orthokeratology and 0.01% Atropine Sequential Treatment for Myopia Control

> **NCT06667037** · NA · RECRUITING · sponsor: **Zhongshan Ophthalmic Center, Sun Yat-sen University** · enrollment: 194 (estimated)

## Conditions studied

- Myopia

## Interventions

- **DEVICE:** Ortho-k lenses
- **DRUG:** 0.01% Atropine

## Key facts

- **NCT ID:** NCT06667037
- **Lead sponsor:** Zhongshan Ophthalmic Center, Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-09-21
- **Primary completion:** 2026-12-31
- **Final completion:** 2027-03-31
- **Target enrollment:** 194 (ESTIMATED)
- **Last updated:** 2025-02-26

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06667037

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06667037, "Orthokeratology and 0.01% Atropine Sequential Treatment for Myopia Control". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT06667037. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*